BG101847A - Human dnase i variants - Google Patents

Human dnase i variants

Info

Publication number
BG101847A
BG101847A BG101847A BG10184797A BG101847A BG 101847 A BG101847 A BG 101847A BG 101847 A BG101847 A BG 101847A BG 10184797 A BG10184797 A BG 10184797A BG 101847 A BG101847 A BG 101847A
Authority
BG
Bulgaria
Prior art keywords
human dnase
variants
actin
relates
resistant variants
Prior art date
Application number
BG101847A
Other languages
Bulgarian (bg)
Other versions
BG64423B1 (en
Inventor
Robert LAZARUS
Steven Shak
Jana Ulmer
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/002366 external-priority patent/WO1996026278A1/en
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of BG101847A publication Critical patent/BG101847A/en
Publication of BG64423B1 publication Critical patent/BG64423B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

The present invention relates to amino acid sequence variantsof human DNase I that have reduced binding affinity for actin. Theinvention provides nucleic acid sequences encoding suchactin-resistant variants, thereby enabling the production of thesevariants in quantities sufficient for clinical use. The inventionalso relates to pharmaceutical compositions and therapeutic usesof actin-resistant variants of human DNase I.22 claims
BG101847A 1995-02-24 1997-08-21 Human desoxyribonuclease i variants BG64423B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/002366 WO1996026278A1 (en) 1995-02-24 1995-02-24 HUMAN DNase I VARIANTS
US54052795A 1995-10-10 1995-10-10

Publications (2)

Publication Number Publication Date
BG101847A true BG101847A (en) 1998-07-31
BG64423B1 BG64423B1 (en) 2005-01-31

Family

ID=24155835

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101847A BG64423B1 (en) 1995-02-24 1997-08-21 Human desoxyribonuclease i variants

Country Status (5)

Country Link
JP (3) JP4624380B2 (en)
BG (1) BG64423B1 (en)
CZ (1) CZ297463B6 (en)
MX (1) MX9706429A (en)
PT (1) PT854927E (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3162372B2 (en) * 1988-12-23 2001-04-25 ジェネンテク,インコーポレイテッド Human DNase
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I

Also Published As

Publication number Publication date
CZ267897A3 (en) 1998-01-14
BG64423B1 (en) 2005-01-31
JP4624380B2 (en) 2011-02-02
CZ297463B6 (en) 2006-12-13
JP2010088452A (en) 2010-04-22
JP2010057516A (en) 2010-03-18
PT854927E (en) 2008-09-08
JP2007312781A (en) 2007-12-06
MX9706429A (en) 1997-11-29

Similar Documents

Publication Publication Date Title
PT910647E (en) Human dnase i hyperactive variants
WO1996034953A3 (en) Cd16-ii variants
IL141021A (en) Use of a polypeptide related to copolymer 1 for preparing a medicament for treating autoimmune diseases
DE69911401D1 (en) Immunoregulator
EP1071443A4 (en) Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
DE69736276D1 (en) HUMAN DNASE RESISTANT AGAINST ACTININHIBITORS
HUT77029A (en) Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
BG101846A (en) HUMAN DNase I VARIANTS
TR199700842T1 (en) �nsan DNase I Varyantlar�.
ATE312179T1 (en) AGENT CONTAINING SERINE-THREONINE KINASE FOR TUMOR THERAPY AND TUMOR DIAGNOSIS
BG101847A (en) Human dnase i variants
DE69730967D1 (en) Human dnase ii
CA2242562A1 (en) Human dnase resistant to actin inhibition
GB2329896A (en) Enzyme and DNA sequence encoding same
YU182791A (en) Tnf-muteini